About 1 in every 10 people in the US who uses Adderall or similar combination drugs to treat attention-deficit/hyperactivity disorder (ADHD) has been affected by an ongoing shortage, a new analysis suggests.
About 1 in every 10 people in the US who uses Adderall or similar combination drugs to treat attention-deficit/hyperactivity disorder (ADHD) has been affected by an ongoing shortage, a new analysis suggests.
The US Food and Drug Administration announced that Adderall was in shortage in mid-October 2022, and the share of people with ADHD who filled their prescriptions for Adderall and related medications plunged in the following months.
In an exclusive analysis for CNN, data from the health data platform Truveta shows that the prescription fill rate for amphetamine/dextroamphetamine medications fell from nearly 49% in October 2022 to a low of less than 41% in February 2023. Overall, the average monthly prescription fill rate was 11% lower in the first half of 2023 than it was in the first half of 2022, and it did not show steady signs of improvement through the end of 2023.
Manufactured shortage. Government shut down one of the largest manufacturers of it for reasons related to the accounting of other pills that manufacturer made, and they're refusing to follow through with the companies efforts to move forward and rectify the situation. This is the government cracking down on purpose.
How can it be just 1 in 10? Neither my fiance or I have been able to get a single prescription for Adderall XR filled on time, with no delays, for over a year.
After a couple of months of not being able to find it, I’ve been fine getting my Adderall from Costco for months now. I think it depends on the formulation and dosage.